|
Re: Riding the Xtandi coat tails
|
4
|
Zenith Epigenetics
|
Sep 12, 2018 11:54PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
5
|
Resverlogix Corp.
|
Jun 14, 2020 07:56PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
9
|
Resverlogix Corp.
|
Jun 15, 2020 12:15PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
2
|
Resverlogix Corp.
|
Jun 16, 2020 02:36AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
8
|
Resverlogix Corp.
|
Jun 13, 2020 12:27PM
|
|
Re: Reviewing post from sometime back in 2015
|
2
|
Resverlogix Corp.
|
Jun 12, 2017 10:51AM
|
|
Re: Reviewing post from sometime back in 2015
|
|
Resverlogix Corp.
|
Jun 12, 2017 10:59AM
|
|
Re: Reverse Split, the good, bad and in between....
|
2
|
Resverlogix Corp.
|
Aug 15, 2018 11:48AM
|
|
Re: Reverse Split, the good, bad and in between....
|
1
|
Resverlogix Corp.
|
Aug 15, 2018 02:40PM
|
|
Re: Reverse Split, the good, bad and in between....
|
2
|
Resverlogix Corp.
|
Aug 14, 2018 01:32AM
|
|
Re: Reverse Split, the good, bad and in between....
|
5
|
Resverlogix Corp.
|
Aug 14, 2018 11:19AM
|
|
Re: Reverse Split Thoughts
|
3
|
Resverlogix Corp.
|
Apr 30, 2023 12:44PM
|
|
Re: Revenue Canada
|
2
|
Resverlogix Corp.
|
Nov 15, 2019 12:42PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:43PM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 11:33AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
1
|
Resverlogix Corp.
|
Dec 02, 2019 12:13PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
2
|
Resverlogix Corp.
|
Nov 02, 2020 10:59PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
5
|
Resverlogix Corp.
|
Nov 02, 2020 12:50PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
6
|
Resverlogix Corp.
|
Nov 02, 2020 01:14PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
8
|
Resverlogix Corp.
|
Nov 02, 2020 06:23PM
|
